Skip to main content
. 2018 Mar 14;10(3):128. doi: 10.3390/v10030128

Table 3.

Treatment status of FcaGHV1 positive and negative lymphoma cases with survival and treatment data available.

Treatment Group FcaGHV1 DNAemic n = 10 (%) FcaGHV1 Negative n = 51 (%)
Multiagent chemotherapy 7 (70.0%) 43 (84.3%)
Prednisolone 1 (10.0%) 3 (5.9%)
No treatment 1 (10.0%) 3 (5.9%)
Unknown 1 (10.0%) 2 (3.9%)